Literature DB >> 1268026

Letter: Blood levels of 5-fluorouracil during intravenous infusion.

M Kawai, J Rosenfeld, P McCulloch, B L Hillcoat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1268026      PMCID： PMC2024988          DOI： 10.1038/bjc.1976.51

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

Authors:  J L Cohen; L E Irwin; G J Marshall; H Darvey; J R Bateman
Journal:  Cancer Chemother Rep       Date:  1974 Sep-Oct

2.  A comparison of 5-fluorouracil administered by slow infusion and rapid injection.

Authors:  C G Moertel; A J Schutt; R J Reitemeier; R G Hahn
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

3.  Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.

Authors:  P Seifert; L H Baker; M L Reed; V K Vaitkevicius
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860
  3 in total
  2 in total

Review 1.  Pharmacokinetic optimisation of anticancer therapy.

Authors:  J Liliemark; C Peterson
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

2.  Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.

Authors:  S Fujii; Y Shimamoto; H Ohshimo; T Imaoka; M Motoyama; M Fukushima; T Shirasaka
Journal:  Jpn J Cancer Res       Date:  1989-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.